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　The 14th GRC on Glycolipid and Sphingolipid Biology 
was organized from 2016/03/06 to 2016/03/11 at the 
Renaissance Tuscany Resort in Il Ciocco, a pretty and 
lovely Italian countryside location far enough from the city 
to prevent dist ract ions, which provided an idea l 
environment for scientific discussion. The objective of this 
conference is to provide a venue and forum for scientists to 
meet and assess the latest progression in the field of 
glycolipid/sphingolipid biology. Around 200 researchers 
with same interests, whether working in the same subject or 
in interdisciplinary, came together in such a highly-
stimulating and non-intimidating environment for a full 
week of intense discussion of the most cutting-edge aspects 
of the glycolipid/sphingolipid biology, in which contained 
one high-quality presentation after another, complemented 
by robust discussions of important scientific topics day 
after day. It was truly a unique and interactive experience.
　The conference program covered a variety of topics with 
an emphasis on mechanism of physiological processes where 
glycolipids/sphingolipids play a prominent role. A number of 
invited speakers such as Professor Yusuf Hannun from Stony 
Brook University, Professor Akio Kihara from Hokkaido 
University, Professor Yoshio Hirabayashi from RIKEN 
presented their latest work and future challenges in a 
informal, interactive format, all of which were fantastic and 
thrilling speech. I asked them some questions and they gave 
me clear answers, which further broadened my knowledge in 
this field. How glycolipid/sphingolipid enzymology pathways 
were regulated and controlled spatially were addressed in the 
first day. The subsequent topics were that glycolipids/
sphingolipids have emerged as critical factors in many 
physiological events, including apoptosis, autophagy, 
regulation of metabolism, cell migration, and play a featured 
role in several diseases, including bacterial and viral 
infections, type 2 diabetes, multiple inflammatory diseases 
and cancer. The availability of suitable technology and new 
developments related to this field was also covered. A large 
portion of the program was dedicated to understanding the 
roles of lipids in physiology and the translation of these 
findings to the clinic. Everyone at the conference was 
approachable, being comfortable asking questions and 
sharing information about their own work. 
　The conference was small and intimate, with opportunities 
for direct communication and the fertile exchange of ideas at 
the frontiers of the glycolipid/sphingolipid biology with 
scientists from the world. I believe I have learned a lot from 
other researchers of different countries. In the meanwhile, I 
built informal networks with some peers, which might lead 
to a lifetime of collaboration and scientific achievement in 
my future research. Without the wonderful conference, I 
would be less willing to share unpublished results and would 
lose opportunities for forging valuable collaborations. On the 
other hand, I got acquainted with some experts in this field 
by discussing with them, and I got some new ideas for my 
research. To be honest, I have found that the conferences 
provided a valuable means of disseminating information and 
ideas in a way that cannot be achieved through the usual 
channels. 
　The poster sessions were also an important part of the 
conference. Posters were displayed in the same room as oral 
presentation. From 16:30 to 18:00, sufficient discussion time, 
was provided. My Posters presentation on 8th March and 10th 
March was deletion of sphingosine 1-phospahte (S1P) 
receptor-2 (S1P2) inhibits lung fibrosis through altering 
alveolar macrophage polarization and senescence in mice. 
This gave me the opportunity to explain the mechanisms and 
significance of S1P2 during the processes of pulmonary 
fibrosis. There were some questions and comments from 
audiences regarding my project. The deepest impression was 
the question from Professor Holleran, Walter M who came 
from University of California. He asked me whether I did the 
experiment about the effect of S1P2 antagonist on lung 
fibrosis, which was to the essential point. Indeed, I observed 
that S1P2 antagonist attenuated lung fibrosis (unpublished data 
in the poster) to further demonstrate my project value that anti-
S1P2 probably is a promising target for treatment of lung 
fibrosis. He also truly appreciated my work by saying a few 
times congratulations to me with sincere and approving smile. 
　In the last day of the productive conference, it was 
announced that my poster was awarded as excellent one 
among 92. It was such an amazing and exciting news for me! 
In the evening, I attended the banquet of this conference. At 
there, I have made more friends with many researchers 
besides the above mentioned peers during scientific 
discussion. We had such fond and sweet memories!
　Taken together, past attendee say: “GRC is high-quality, 
cost-effective meetings and have been recognized as the 
world’s premier scientific conferences.” I found it truly 
worthy of the reputation until I joined it in person.
　Finally, I would like to extend my deepest thanks to the 
Kato Memorial Bioscience Foundation that had supported 
me the budget to participate this conference.
